Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in!
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Ragy Girgis, MD, MS
JCP
Insights
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
June 6, 2025
In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by...
Ragy Girgis
JCP
Insights
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 2
June 6, 2025
In Part II of his video, Dr. Ragy Girgis examines D3 receptor binding by antipsychotics and its potential to improve negative symptoms in schizophrenia.
Ragy Girgis